Dementia Researcher

Welcome to the seventh season of the Dementia Researcher X ISTAART PIA Relay Podcast. Across six episodes, leading early career and senior researchers hand the mic from one ISTAART PIA to the next, giving you an honest, peer-to-peer tour of where dementia research is actually heading, from wearables and biomarkers to policy and trial design, in the run-up to AAIC.Series closer, and the relay comes full circle: Carla Abdelnour, who hosted episode one, returns as the guest. Carla is a clinician scientist in Barcelona and incoming Chair of the ISTAART Clinical Trials Advancement and Methods PIA, working on mixed neurodegenerative disease, particularly Lewy body and Alzheimer's pathology together. With host Sindhuja Tirumalai Govindarajan she explains why co-pathology is so common and what it means for treatment: does someone with both alpha-synuclein and Alzheimer's pathology respond to an anti-amyloid drug the same way as someone without? They discuss why she leans on fluid biomarkers, the wish for a synuclein PET tracer, and how trials might stratify or include people by co-pathology. Carla makes a useful point for anyone designing research, that clinical trial methods translate straight to observational studies, and previews the CTAM PIA's AAIC programme, including a panel and featured session on global representation in trials.TakeawaysMixed pathology is common, and co-occurring alpha-synuclein and Alzheimer's pathology may change how people respond to treatment.Trials could stratify or include people by co-pathology, but alpha-synuclein is currently detectable only in CSF, which limits that.Fluid biomarkers offer the specificity to track different proteinopathies and, potentially, response to treatment.Clinical trial design transfers straight to observational research: the same inclusion criteria, outcomes and sample-size thinking.Global representation in trials is a live priority, with a CTAM panel launching at AAIC.--The Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) convenes the global Alzheimer’s and dementia science community. Members share knowledge, fuel collaboration and advance research to find more effective ways to detect, treat and prevent Alzheimer’s and other dementias. Professional Interest Areas (PIA) are an assembly of ISTAART members with common subspecialties or interests.There are currently 30 PIAs covering a wide range of interests and fields, from Neuroimaging to Diversity and Disparities and everything in between.Find out more at https://istaart.alz.org/--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

Welcome to the seventh season of the Dementia Researcher X ISTAART PIA Relay Podcast. Across six episodes, leading early career and senior researchers hand the mic from one ISTAART PIA to the next, giving you an honest, peer-to-peer tour of where dementia research is actually heading, from wearables and biomarkers to policy and trial design, in the run-up to AAIC.Most people with hypertension after 50 never develop dementia, so what separates those who do? That is the question driving Dr Sindhuja Tirumalai Govindarajan, a neuroimaging researcher and outgoing Chair of the ISTAART PEERs PIA, recorded as she moves from a postdoc at the University of Pennsylvania to an assistant professorship at the Karolinska Institute. With host Dr Joe Kane she explains how machine learning on tens of thousands of MRI scans can pick up subtle brain changes years before symptoms, and why scans from different scanners have to be harmonised first. The conversation then turns to PEERs itself, a PIA built not around one research area but around early career researchers everywhere, and the work of levelling opportunity across borders through local routes like Neuroscience Next, WYLD and INTERDEM Academy. Sindhuja runs through the PIA's AAIC workshops, from narrative CVs to social bingo for ECRs, and closes with practical advice on getting people involved: make the ask specific.TakeawaysMachine learning on large MRI datasets can detect brain changes years before any cognitive symptoms show.Scans from different scanners must be harmonised first, stripping out machine noise so only the biology remains.PEERs exists to level opportunity for early career researchers wherever they are, across every research area.Local routes such as Neuroscience Next, WYLD and INTERDEM Academy widen access for those who cannot get to the big conference.Interest among ECRs is common but clarity often is not, so make the ask specific and people will step up.--The Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) convenes the global Alzheimer’s and dementia science community. Members share knowledge, fuel collaboration and advance research to find more effective ways to detect, treat and prevent Alzheimer’s and other dementias. Professional Interest Areas (PIA) are an assembly of ISTAART members with common subspecialties or interests.There are currently 30 PIAs covering a wide range of interests and fields, from Neuroimaging to Diversity and Disparities and everything in between.Find out more at https://istaart.alz.org/--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

Welcome to the seventh season of the Dementia Researcher X ISTAART PIA Relay Podcast. Across six episodes, leading early career and senior researchers hand the mic from one ISTAART PIA to the next, giving you an honest, peer-to-peer tour of where dementia research is actually heading, from wearables and biomarkers to policy and trial design, in the run-up to AAIC.Lewy body pathology shows up in roughly 30% of the brains of people who had dementia, yet it gets diagnosed in only about 5% of cases. Closing that gap has shaped much of Dr Joe Kane's career. Joe is a geriatric psychiatrist at Queen's University Belfast and outgoing Chair of the ISTAART Lewy Body Dementias PIA, and with host Dr Patrick Lao he traces his work from the Diamond Lewy programme to consensus diagnostic guidelines built by Delphi process. They discuss the symptoms clinicians often miss because they don't think to ask, from constipation to loss of smell, the cardiac scans and seed amplification assays now detecting pathology in CSF and even skin, and the TOP HAT trial repurposing an anti-sickness drug for hallucinations. Joe makes the case for a Lewy body specific rating scale, explains why the prodrome may be psychiatric or delirium rather than cognitive, and runs through the PIA's biggest AAIC programme in years, including a PIA Day panel on seed amplification assays.TakeawaysLewy body dementia is heavily underdiagnosed: pathology appears in about 30% of brains but is diagnosed in around 5%.Much of the disease shows outside the brain, in constipation, blood pressure and smell, so it gets missed if nobody asks.Seed amplification assays, now usable on CSF and even a small skin biopsy, are changing how the pathology is detected.Trials can fail on the wrong yardstick, which is why the PIA is building a Lewy body specific rating scale.The prodrome is not only cognitive; the first sign can be depression, psychosis or delirium, and those gaps need data.--The Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) convenes the global Alzheimer’s and dementia science community. Members share knowledge, fuel collaboration and advance research to find more effective ways to detect, treat and prevent Alzheimer’s and other dementias. Professional Interest Areas (PIA) are an assembly of ISTAART members with common subspecialties or interests.There are currently 30 PIAs covering a wide range of interests and fields, from Neuroimaging to Diversity and Disparities and everything in between.Find out more at https://istaart.alz.org/--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

Welcome to the seventh season of the Dementia Researcher X ISTAART PIA Relay Podcast. Across six episodes, leading early career and senior researchers hand the mic from one ISTAART PIA to the next, giving you an honest, peer-to-peer tour of where dementia research is actually heading, from wearables and biomarkers to policy and trial design, in the run-up to AAIC.Almost everyone born with Down syndrome overproduces the amyloid precursor protein from birth, which makes it one of the clearest natural windows we have into how Alzheimer's begins. Dr Patrick Lao, Assistant Professor at Columbia and Programmes Chair of the ISTAART Down Syndrome and Alzheimer's Disease PIA, comes from a medical physics background and uses multimodal neuroimaging to map the disease across its genetic and sporadic forms. With host Lillian Morgado, he explains amyloid and tau PET, Thal phases and Braak staging, and how chronological age can stand in for disease stage in this population, with a typical symptom onset around 54. They talk about why people with Down syndrome were long left out of anti-amyloid trials and how that is now changing, and the risk and resilience research asking why some people fall off the expected timeline. Patrick also previews the PIA's AAIC PIA Day session on returning results, plus the separate DSAD/ADAD conference coming to London next year.TakeawaysGenetic forms of Alzheimer's, including Down syndrome, let researchers study the earliest disease pathways before symptoms appear.In Down syndrome, chronological age can approximate disease stage, with symptoms typically expected around age 54.Imaging shows where amyloid and tau sit in the brain, the spatial detail a blood test cannot give.People with Down syndrome were historically excluded from anti-amyloid trials; that is shifting, with a lecanemab safety extension now underway.Not everyone follows the population timeline, and risk and resilience work asks what pushes onset earlier or later.--The Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) convenes the global Alzheimer’s and dementia science community. Members share knowledge, fuel collaboration and advance research to find more effective ways to detect, treat and prevent Alzheimer’s and other dementias. Professional Interest Areas (PIA) are an assembly of ISTAART members with common subspecialties or interests.There are currently 30 PIAs covering a wide range of interests and fields, from Neuroimaging to Diversity and Disparities and everything in between.Find out more at https://istaart.alz.org/--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

Welcome to the seventh season of the Dementia Researcher X ISTAART PIA Relay Podcast. Across six episodes, leading early career and senior researchers hand the mic from one ISTAART PIA to the next, giving you an honest, peer-to-peer tour of where dementia research is actually heading, from wearables and biomarkers to policy and trial design, in the run-up to AAIC.If we cured Alzheimer's tomorrow but did no work on cost, distribution or access, we would have cured it only for the richest people in the world. That line from Lillian Morgado sits at the centre of this episode. Lillian is a research coordinator at Georgia State University and Communications Chair of the ISTAART Health Policy PIA, working mainly in qualitative research and legal epidemiology. With host Dr Vanessa Young, she talks through what qualitative work actually involves, her research on caregivers and people with dementia in the justice system, and the question that opened up next: what happens to someone with no caregiver to advocate for them. They get into why AI and blood-based biomarkers are as much policy problems as scientific ones, how regulation differs across borders, and why policy is the bridge that decides whether science reaches the people it was meant for. Lillian also runs through the Health Policy PIA's busy week at AAIC, from PIA Day to a featured research session on dementia care across countries.TakeawaysPolicy is the bridge from the lab to the patient; without it, a breakthrough only reaches the few who can already afford care.Qualitative interviews and coding surface the right questions before the big quantitative money goes in.Caregivers matter enormously when someone with dementia meets the justice system, which raises the question of those who have none.AI and blood-based biomarkers carry legal and access questions, and the rules differ between, say, the US and Europe under GDPR.You do not join a PIA because you already belong; you belong because you get involved, and you need not be an expert to contribute.--The Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) convenes the global Alzheimer’s and dementia science community. Members share knowledge, fuel collaboration and advance research to find more effective ways to detect, treat and prevent Alzheimer’s and other dementias. Professional Interest Areas (PIA) are an assembly of ISTAART members with common subspecialties or interests.There are currently 30 PIAs covering a wide range of interests and fields, from Neuroimaging to Diversity and Disparities and everything in between.Find out more at https://istaart.alz.org/--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

Welcome to the seventh season of the Dementia Researcher X ISTAART PIA Relay Podcast. Across six episodes, leading early career and senior researchers hand the mic from one ISTAART PIA to the next, giving you an honest, peer-to-peer tour of where dementia research is actually heading, from wearables and biomarkers to policy and trial design, in the run-up to AAIC.Sleep might be one of the earliest windows we have into brain health, and Dr Vanessa Young thinks the way we measure it is about to change. Fresh from finishing her PhD in May, Vanessa is a postdoc at the Glenn Biggs Institute and Communications Chair of the Technology and Dementia PIA. She studies sleep and the ageing brain, where the relationship seems to run both ways: as dementia develops, sleep gets worse, and poor sleep may feed back into the disease. With host Dr Carla Abdelnour, she gets into digital biomarkers, why wearables let you capture sleep continuously at home rather than in a one-off sleep study, and the move from wearables to "nearables", bed sensors and room radar that ask nothing of the participant at all. They also cover the analysis headache that comes with years of continuous data, the equity problem when a study needs home Wi-Fi, and what the PIA has planned for its full-day AAIC preconference on AI.TakeawaysSleep and dementia feed each other, so sleep is worth studying as somewhere we might actually step in and help.Wearables capture sleep night after night at home, which reaches people who live nowhere near a big sleep centre.The field is shifting from wearables to "nearables", sensors in the mattress or radar in the room, to cut participant burden and bias.Years of continuous data brings its own problem: telling meaningful signal apart from background noise.If a study needs Wi-Fi to send its data, it quietly excludes people, so digital equity has to be designed in.--The Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) convenes the global Alzheimer’s and dementia science community. Members share knowledge, fuel collaboration and advance research to find more effective ways to detect, treat and prevent Alzheimer’s and other dementias. Professional Interest Areas (PIA) are an assembly of ISTAART members with common subspecialties or interests.There are currently 30 PIAs covering a wide range of interests and fields, from Neuroimaging to Diversity and Disparities and everything in between.Find out more at https://istaart.alz.org/--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

Most people with dementia live, and many die, at home. The person who knows them best in those final months is often not a clinician but a home care worker coming through the door several times a day, doing some of the hardest work in the dementia pathway with little training and almost no research behind them. This episode asks what good home care actually looks like, why it is so hard to deliver, and what one study is doing about it.Host Dr Alice Carstairs is joined by the PALLDEM Homecare team from the Cicely Saunders Institute at King's College London: Dr Lesley Williamson, who co-leads the study; research assistant Annika Dhawan, who runs the engagement work; and Dr Clare Ellis-Smith, who developed the IPOS Dem outcome measure. They are joined by lived experience expert Alan Richardson, who cared for his mother for 15 years, and Tony O'Flaherty, director at Home Instead Wandsworth, Lambeth and Dulwich.Together they cover what IPOS Dem is, why home care gets so little attention, what it really takes to get a tool used on the ground, and why recognition for this workforce is overdue.Essential Links:Famileo - https://bit.ly/FamileoDR26PALLDEM-Homecare - https://bit.ly/4e6bdvdIPOS-Dem - https://bit.ly/4vJgkaAKey topics:Role of home care workers in dementia supportImplementation of iPOSDEM in home care settingsChallenges and solutions in home care for dementiaResearch and innovation in community dementia careThis episode is sponsored by Famileo. Helping families living with dementia stay close with a personalised printed magazine, delivered monthly. Over a quarter of a million families already use Famileo to stay connected. First month free with code DR26. https://bit.ly/FamileoDR26--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs--This podcast is sponsored by Famileo. The sponsor had no involvement in the planning, production, editorial decisions, or content of this episode.

In this episode, Professor Louise Serpell brings together Dr Niranjan Bose from the Alzheimer's Disease Data Initiative, Jonathan Hoover from the AI company Prima Mente, and Dr Kexin Huang from Stanford University and Biomni AD. They discuss the Alzheimer’s Insights AI Prize and what agentic AI could mean for the future of dementia research.We hear about the Alzheimer’s Disease Data Initiative and AD Workbench, and their role in making research data more accessible, usable and secure. The conversation also looks at how the Alzheimer’s Insights AI Prize could help researchers make better use of that data, turning complex resources into practical tools for discovery.Kexin introduces Biomni AD, an AI research assistant designed to help scientists develop questions, bring data together and move from ideas to results more efficiently. Jonathan introduces Parthenon and Athena, a virtual wet lab system that helps researchers model cell states, test perturbations and plan experiments.Together, the guests consider how AI can support researchers without replacing human judgement, and why confidence in using these tools is likely to become an important skill for dementia researchers.Essential Links:Sign up for AD WorkbenchLearn more about the AD Data InitiativeLearn more about the Alzheimer's Insights AI Prize Prima MenteBiomni-ADIn this episode:AI can support researchers by helping with data, workflows and experimental planning, but it still needs human judgement, review and validation.AD Workbench from Alzheimer's Disease Data Initiative is helping make dementia research data more accessible, usable and secure, giving researchers better ways to work across complex datasets.Agentic AI could help researchers move more quickly from a research question to an analysis plan, useful evidence or a possible experiment.Biomni AD, Parthenon and Athena show how AI tools are becoming more specialised, from research assistants to virtual wet lab systems.AI literacy is likely to become an important skill for dementia researchers, including those without coding or data science backgrounds.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

What happens when academia no longer feels like the right fit, but research still does?In this episode, Adam Smith is joined by Dr Ellice Parkinson from Health Innovation East, Elizabeth 'Lizzie' English from the British Heart Foundation, and Dr Alice Carstairs from Alzheimer’s Society to talk about leaving academia while staying connected to research.Together, they explore the career turns that took them from PhDs and lab work into roles in health innovation, charity, policy, evaluation, public engagement and research communications. They discuss what helped them make the move, what felt difficult, and how skills built in academia can be used in many different settings.The conversation covers identity, confidence, networking, mentoring, transferable skills, and the quiet pressure many researchers feel to stay on a traditional academic path. It also challenges the idea that leaving academia means leaving research behind.For PhD students, early career researchers, and anyone wondering what else might be possible, this episode offers practical advice, reassurance, and examples of careers where research still sits at the centre of meaningful work.In this episode:Explore how researchers transition from academia to impactful roles in health innovation, research impact analysis, and science communication.Discover the metaphor of "doors" in academic careers and how choosing different paths can sustain meaningful research.Hear personal stories from former PhD students who found success and fulfillment outside traditional university settings.Learn about the transferable skills that ease the transition into non-academic roles and how to leverage them.Gain insights into the importance of networking, mentorship, and aligning career choices with personal passions and societal needs.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

Globally, women are twice as likely as men to experience depression and anxiety, and the risk peaks at moments of hormonal change: postpartum, the luteal phase, perimenopause. Why?In this episode of XXplored, host Dr Laura Stankeviciute, University of Gothenburg is joined by Professor Vibe Gedsø Frøkjær, a leading researcher on serotonin and sex hormones at the University of Copenhagen, and Franziska Weinmar, a psychoneuroendocrinology PhD researcher at the University of Tübingen and host of the Let's Talk About Women podcast.They get into the biology behind hormone shift sensitivity, what oestrogen actually does to the serotonin system, and why the gut-brain axis might matter more for women's mental health than most clinicians appreciate. They also tackle hormonal contraception and depression risk, why suicide statistics look so different by gender, and where the field still has big gaps to close.Key takeawaysWomen are twice as likely as men to experience depression and anxiety, with risk clustering around hormonal transitions.The serotonin system is built to respond to sex hormones, which makes it a likely route by which hormonal shifts affect mood.Women differ in how sensitive their brains are to hormone shifts, and that sensitivity helps explain why some experience mood symptoms and others don't.The gut-brain axis is a real frontier for women's mental health, and may open up new treatment options through drug repurposing.Hormonal contraception works well for most women but carries a small heightened risk of depression that clinicians should counsel on more openly.Emotion regulation is a trainable skill and a useful clinical target across hormonal transitions.Gender differences in suicide reflect both how distress is expressed and how the care system recognises and responds to it.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

Extended reality is starting to find a real place in dementia research and care. In this episode, host Dr Byron Creese is joined by David de Jong-Bambagioni, Dr Emilie Brotherhood, and Alice Rowe to explore how virtual, augmented, and mixed reality tools are being used in practice.Together, they discuss how XR is helping to standardise cognitive assessments, simulate clinical environments, and support earlier and more accurate diagnosis. The conversation also looks at how immersive tools are being used to build empathy, giving clinicians and carers a better sense of what it might feel like to live with dementia.The panel share examples from their own work, including virtual simulations to distinguish delirium from dementia, and digital environments designed to capture subtle behavioural changes in conditions like frontotemporal dementia. These approaches are opening up new ways to study cognition, behaviour, and patient experience in more realistic and scalable settings.This episode offers a practical look at where XR is already making a difference, and where it might go next.In this episode:How XR is being used in dementia research and careUsing immersive environments for assessment and empathyWhy co design and lived experience matterVirtual, augmented, and mixed reality explained simplyEthical risks and safeguards in vulnerable groupsHow researchers are moving into digital healthGetting started with XR and finding collaboratorsInclusion, global perspectives, and reducing bias--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

In this episode of the Dementia Researcher Podcast Dr Anna Volkmer hosts a discussion exploring the complexities of wandering in dementia care.Dr Bryony Waters-Harvey & Dr Emma Hock from The University of Sheffield and Conny McGowan from The Orders of St John Care Trust discuss their research and outcomes of the NIHR funded "FREEDEM study" - Reframing 'wandering' as a meaningful activity using realist synthesis and qualitative explorationTakeawaysWandering is often a meaningful activity for residents.Individualised care plans are crucial for supporting residents.Language matters in how we perceive wandering.Positive risk-taking can enhance residents' quality of life.Hydration and nutrition are important for wandering residents.Research should focus on the positive aspects of wandering.Care staff need training to support safe wandering.Environmental factors significantly impact wandering behavior.Residents should have access to outdoor spaces.Future research should involve residents and their familiesAccess the toolkit and resources:https://sites.google.com/sheffield.ac.uk/freedem/homeStrategies to support safe wandering in care homes for older adults – what works, for whom, and in which circumstances? A realist synthesis:https://www.sciencedirect.com/science/article/pii/S0020748926000192--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

This episode of the Dementia Researcher Podcast continues our coverage from the AD PD Conference 2026 in Copenhagen, one of the largest international meetings focused on Alzheimer’s and Parkinson’s disease.Hosted by Professor Louise Serpell, the conversation brings together Athina Grigoriou, Dr Lauren O’Neill, and Dr Sofie Let Frandsen, each sharing highlights from across the conference.The discussion spans a wide range of topics, from the biological role of alpha synuclein and mitochondrial dysfunction, through to emerging therapeutic targets and the growing importance of biomarkers. There is a strong focus on how diseases are more complex and varied than once thought, with increasing attention on stratification, personalised medicine, and early detection.Alongside the science, the episode also reflects on the importance of patient voices, collaboration across disciplines, and the value of sharing both positive and negative research findings.This is Part Two of our AD PD 2026 reflections, offering a thoughtful look at where the field is heading next.ADPD Conference Website - adpd.kenes.com/Top Takeaways:Alpha synuclein may have a normal physiological role, not just a pathological oneMitochondrial dysfunction remains central in Parkinson’s mechanismsBiomarkers are key for both early detection and patient stratificationDiseases like Parkinson’s and dementia are highly heterogeneousPersonalised medicine is becoming a realistic goal, not just an ideaNew therapeutic targets beyond dopamine are emergingEarly stage and presymptomatic intervention is a major focusPatient and carer perspectives remain underrepresented but essentialCollaboration and openness, including sharing negative results, are vitalMore diverse populations are needed to validate biomarkers globally--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

This episode of the Dementia Researcher Podcast comes from the AD PD Conference 2026 in Copenhagen, bringing together global researchers to share the latest in Alzheimer’s and Parkinson’s disease research.Hosted by Professor David Cash, the episode features Grace Thompson, Dr Marieta Vassileva, and Dr Alice Carstairs, each offering their own highlights from across the conference.Rather than trying to cover everything, the conversation focuses on standout talks and emerging themes. These include advances in biomarkers, growing interest in co pathology, the role of neuroinflammation, and how new tools like AI and multiomics are changing how we understand disease.Across the discussion, the group reflects on what new findings might mean for diagnosis, treatment, and the future direction of dementia research. There is also a strong sense of optimism, with the field moving towards combination therapies and earlier intervention.This is Part One of a two part series capturing reflections from the conference.ADPD Conference Website - adpd.kenes.com/Top Takeaways:Biomarkers are now central across diagnosis, prediction, and trialsCo pathology is a major theme, with diseases rarely existing in isolationTau is emerging as a key driver of cognitive declineMicroglia and neuroinflammation offer new therapeutic targetsMultiomics is helping uncover detailed disease mechanismsAI is becoming essential for handling complex datasetsEarly career researchers are playing a visible role at major conferencesSynaptic loss is strongly linked to cognitive declineCombination therapies are increasingly seen as the futureThe field feels more optimistic than in previous yearsA transcript of this show, links and show notes and profile on all our guests are available on our website at www.dementiaresearcher.nihr.ac.ukFollow us on social media:www.instagram.com/dementia_researcher/www.facebook.com/Dementia.Researcher/www.twitter.com/demrescommunitywww.linkedin.com/company/dementia-researcherwww.bsky.app/profile/dementiare…archer.bsky.socialDownload and Register with our Community App:www.onelink.to/dementiaresearcher

Primary progressive aphasia (PPA) is a group of language led dementias where communication difficulties appear before memory loss. Despite this, diagnosis can often take years and access to specialist support remains inconsistent.In this episode of the Dementia Researcher Podcast, Dr Annalise Rahman Filipiak speaks with Professor Jason Warren, Dr Anna Volkmer and Dr Jacqueline Kindell about the role of speech and language therapy in diagnosing and supporting people living with PPA. The discussion explores why diagnosis is often delayed, how speech and language therapists contribute to multidisciplinary assessment and care pathways, and why early referral can make a meaningful difference for patients and families.The conversation also looks at international differences in access to services, the importance of communication support across the course of the condition, and the growing global movement to improve awareness through Primary Progressive Aphasia Awareness Day.PPA Awareness Day 2026 - speechtherapyppa.com/ppa-awareness-dayAbout the guestsJason Warren - Professor of Neurology at University College London and the National Hospital for Neurology and Neurosurgery. His research focuses on dementia, language disorders and diagnostic markers for primary progressive aphasia.Anna Volkmer - Associate Professor and Consultant Speech and Language Therapist at University College London. Her work focuses on communication interventions and support for people living with primary progressive aphasia and their families.Jacqueline Kindell - Speech and Language Therapist and Lecturer at The University of Manchester with extensive clinical and research experience in dementia and communication disorders.Key TakeawaysPrimary progressive aphasia is a group of dementias where language difficulties appear before memory problems, which often makes diagnosis harder.Diagnosis can take several years because many dementia assessment tools focus on memory rather than communication and language.Speech and language therapists play an important role in diagnosing PPA by assessing language, communication and motor speech changes.Speech and language therapy is currently the main treatment available to help people with PPA manage communication difficulties.Early referral to speech and language therapy helps people and families adapt communication strategies and plan for future changes.Access to specialist speech and language therapy services varies widely depending on where people live.Communication support can improve quality of life and reduce wider pressures on health services by improving understanding between patients, families and clinicians.Primary Progressive Aphasia Awareness Day aims to improve recognition of the condition and promote early referral to speech and language therapy.A transcript of this show, links and show notes and profile on all our guests are available on our website at www.dementiaresearcher.nihr.ac.ukFollow us on social media:www.instagram.com/dementia_researcher/www.facebook.com/Dementia.Researcher/www.twitter.com/demrescommunitywww.linkedin.com/company/dementia-researcherwww.bsky.app/profile/dementiare…archer.bsky.socialDownload and Register with our Community App:www.onelink.to/dementiaresearcher

In this episode, Professor Louise Serpell is joined by 2026 Rainwater Prize winners Professor Dennis Dickson, Professor Melissa Murray and Dr Marc Busche.They talk about their work and the science that led to them earning this much deserved award, reflecting on decades of research into tau and its role in neurodegenerative disease. The conversation explores how tau functions in the healthy brain, how it becomes harmful in conditions such as Alzheimer’s disease and progressive supranuclear palsy, and why certain brain regions are especially vulnerable.The discussion covers different forms of tau, including soluble species that may disrupt how neurons fire before visible tangles appear. Brain banking, imaging and fluid biomarkers are highlighted as key tools for understanding disease differences and improving diagnosis. The importance of rare MAPT mutations and what they can teach us about future treatments is also explored.Alongside the science, there are thoughtful reflections on mentorship, risk taking and the value of asking ambitious questions in dementia research.Key TakeawaysTau is essential but context dependent. It is vital for normal brain function, yet changes in its chemistry, structure or location can drive neurodegeneration.Tangles are not the whole story. Soluble tau species can disrupt neuronal firing, even in single cells, before visible aggregates appear.Selective vulnerability defines tauopathies. Disorders such as PSP consistently affect specific brain regions & cell types, including glia, & we do not fully understand why.One biomarker does not fit all. Tau PET and fluid markers behave differently across Alzheimer’s disease and primary tauopathies, reflecting structural differences in tau.Progress depends on bold science. High risk experiments, strong mentorship and access to the right tools are essential for moving the field forward.Find out more about the Rainwater Foundation:https://rainwatercharitablefoundation.org/--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

In this episode of the Dementia Research Podcast, host Dr Gemma Lace is joined by guests, Dr Eric Hill from Loughborough University, Kalliopi Mavromati from University of Glasgow, Natalie Wickett from Simon Fraser University and Dr Kate Harris from Newcastle University.Together they discuss the intersection of ADHD and research, exploring personal experiences, misconceptions, and coping strategies. The conversation highlights the unique challenges faced by researchers with ADHD, the importance of understanding and empathy in academic settings, and the various ways individuals navigate their symptoms. The discussion also touches on the role of medication and the need for tailored approaches to support neurodiverse individuals in academia.Key takeawaysADHD is often misunderstood and is much more than visible hyperactivity.People with ADHD do not lack attention, but can struggle to direct it consistently.Hyperfocus can lead to intense productivity, followed by emotional or physical crashes.Academic culture, with its constant evaluation and rejection, can amplify ADHD challenges.Rejection sensitivity can feel physically painful and trigger fight or flight responses.Clear expectations and structured communication reduce anxiety and procrastination.Breaking work into smaller deadlines can support momentum and reduce overwhelm.Medication can be life changing for some, but it is not a complete solution on its own.Hormonal shifts can significantly influence ADHD symptoms, particularly for women.Curiosity, empathy and flexibility create more supportive research environments for neurodivergent colleagues.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

In this episode of the Dementia Researcher podcast, host Adam Smith chats with with Professor Paul Freemont and researcher Tom Adam from the UK Dementia Research Institute at Imperial College London to discuss the critical issue of urinary tract infections (UTIs) in individuals living with dementia.The conversation highlights the complexities of diagnosing UTIs in people living with dementia, where communication barriers and atypical presentations often lead to misdiagnosis and unnecessary hospitalisations. The guests emphasise the urgent need for improved detection methods, as UTIs can exacerbate cognitive decline and lead to severe health complications. They talk about their work to develop and introduce an innovative novel point-of-care diagnostic device designed specifically for dementia patients, which aims to facilitate early detection of UTIs in a home and care home setting, thereby reducing the reliance on traditional symptom reporting and hospital visits.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

In this episode of the Dementia Researcher Podcast, we focus on Lewy body dementia and why it remains one of the most misunderstood and frequently misdiagnosed forms of dementia.Released ahead of Lewy Body Dementia Day on 28 January, the conversation explores what Lewy body dementia is, how it sits between existing diagnostic categories, and why it often takes years for people to receive the right diagnosis.Host Dr Sam Moxon is joined by three researchers working on Lewy body dementia from very different angles. Dr Ece Bayram, Assistant Research Professor at the University of Colorado Anschutz, whose work explores differences in risk, progression and diagnosis across sex, gender, ethnicity and race. Dr Joe Kane, Consultant Psychiatrist and Clinical Lecturer, who combines clinical care with research into diagnosis, service delivery and clinical trials. Dr David Koss, Lecturer and Group Lead at the University of Dundee, studying the cellular and molecular mechanisms underlying Lewy body dementiaTogether, they unpack why Lewy body dementia does not follow a neat clinical pathway, how overlapping symptoms can lead to confusion with Alzheimer disease or Parkinson disease, and why uncertainty in diagnosis affects everything from care planning to research outcomes.The discussion highlights the real world consequences of misdiagnosis, including inappropriate treatments, faster than expected progression, and the emotional toll on families and care partners. The guests also reflect on how limited awareness of Lewy body dementia continues to shape health services, research recruitment and public understanding.Across the episode, a clear theme emerges: Lewy body dementia cannot be understood from a single perspective. Clinical insight, biological research and population level studies all need to connect if progress is to be made.Key takeawaysLewy body dementia includes dementia with Lewy bodies and Parkinson disease dementiaSymptoms extend beyond memory and can include hallucinations, sleep disturbance, fluctuations and movement changesDiagnosis is frequently delayed due to overlapping features with other dementiasMisdiagnosis can lead to harmful treatments and inappropriate care planningCare partners play a central role in both diagnosis and ongoing supportResearch cohorts often lack diversity, limiting understanding of theCellular mechanisms such as alpha synuclein dysfunction remain an important area of studyEarly and accurate diagnosis improves care, planning and research qualityMultidisciplinary collaboration is essential to understanding the diseasePublic awareness is key to improving detection, funding and outcomes--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

This episode shares highlights from the UK Dementia Research Institute (UKDRI) Connectome Conference. Host Dr Anna Mallach is joined by Dr Dayne Beccano Kelly, Dr Beth Eyre, and Tom Adam to reflect on talks, posters, and discussions that stood out.The conversation covers lived experience sessions, keynote talks, early career presentations, and how informal conversations and parallel sessions shaped ideas and potential collaborations. The episode offers a snapshot of the breadth of work presented across the institute and the importance of connecting people as well as science.Find out more about the UKDRI:https://www.ukdri.ac.uk/Watch our YouTube Shorts Series, with conference attendees presenting their posters in under 3 minutes: https://www.youtube.com/playlist?list=PLeUI1GHB4EvRFJl8tRC-wq5RxkDKF9twU--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

This festive charity debate asks a question nobody saw coming but everyone had an opinion on. Would Santa Claus make a good principal investigator?Recorded live in the Dementia Researcher Community, this Christmas special brings humour, sharp thinking, and real reflections on leadership, research culture, ethics, and academia.The debate is hosted by Adam Smith and Dr Anna Volkmer.Speaking for the motion is Rebecca Williams, PhD researcher exploring FTD and apathy.Speaking against the motion is Dr Connor Richardson, Research Fellow working in data science, epidemiology, and machine learning in dementia research.Through opening statements, rebuttals, and audience questions, the discussion ranges from logistics and mentorship to ethics, transparency, wellbeing, and what good leadership really looks like in research. While lighthearted on the surface, the debate reveals some very familiar academic tensions beneath the tinsel.This episode was recorded as a charity event in support of Dementia UK and their Admiral Nurses, who provide vital support to people living with dementia and their families, especially during the Christmas period.Thank you for listening, watching, and supporting dementia research and care.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

This festive special flips the script on polished papers and perfect protocols. Dr Fiona McLean is joined by Dr Ian Harrison, Dr Soraya Meftah, and Dr Kate Harris to share the research moments that did not go to plan but taught them far more than success ever could.From ELISAs gone rogue and antibodies that refuse to behave, to admin systems that quietly derail months of planning, this episode is a reminder that real research is messy, unpredictable, and occasionally hilarious. The conversation moves easily between lab disasters, student supervision realities, near misses with fire, and the emotional rollercoaster of academic life.It is light hearted, reassuring, and (hopefully) relatable. A permission slip to laugh, reflect, and remember that being wrong is often part of doing good science.Merry Christmas from all of us!Top takeawaysMost experiments do not fail, they redirectUnexpected results often open better research questionsRushing protocols almost always backfiresAdmin failures can be as stressful as lab failuresTalking openly about what went wrong saves time and moneyStudents learn more from troubleshooting than from perfect resultsPublishing negative findings can help an entire fieldBeing wrong is built into the scientific methodGiving yourself time and mental space mattersIf no one was hurt, it is probably recoverable--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

In this episode of the Dementia Researcher podcast we look at how dementia clinical trials reach far beyond medicines. Host Dr Annalise Rahman Filipiak speaks with Dr Elizabeth Rhodus, Dr Inga Antonsdottir, and Dr Elisa França Resende about entering the field, working with behavioural and community based interventions, and learning the skills needed to deliver rigorous, reproducible studies that still respect the individual needs of participants.The guests discuss their routes into trials, what surprised them, what they wish they had known earlier, and how mentorship and collaboration shaped their progress. They touch on trial design, regulatory processes, cultural considerations, and the value of early career networks that support researchers across different countries.Topics coveredWhat early career researchers find challenging about trial methodsWorking in homes and communitiesDesigning sensory and environmental interventionsLiteracy based trials in Brazil and issues of inclusionMentorship, networks and training programmesTrial rigour, manuals, assessments and reproducibilityRegulatory hurdles and timeframesPractical advice for researchers wanting to deliver a trial as part of their research--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

In this episode of the Dementia Researcher - Xxplored Women’s Brain Health podcast, host Dr Laura Stankeviciute speaks with Professor Claudia Barth from Charite University and Dr Gillian Coughlan from Harvard Medical School to examine the midlife transition, menopause and its significance for women’s brain health.Together they outline what the menopause truly involves across the early, late, and post stages, and explain how hormonal change affects brain structure, energy use, mood, and cognition. They also explore why this period may coincide with greater vulnerability to later Alzheimer’s disease and discuss the role of early or surgical menopause, symptom severity, and gaps in existing research cohorts.The episode highlights the need for richer reproductive data, real time biomarker studies, and closer collaboration with digital health tools to better capture women’s lived experiences. It reflects a growing wave of research and public interest aimed at improving understanding, support, and evidence based care during this important life stage.TakeawaysMenopause is a long transition shaped by fluctuating hormones.Cognitive and mood symptoms reflect changes in brain networks.Earlier menopause is linked with increased later Alzheimer’s risk.Major research cohorts lack detailed reproductive data.New real time studies are beginning to track symptoms and biomarkers.Digital tools will be key for future research.Better global representation is needed across studies.Momentum is building to close long standing gaps in women’s health.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

In this episode, host Dr Anna Volkmer is joined by Dr Alys Griffiths, Sophie Jeffery, and Esther Whittlesea Reed to explore a two-year Alzheimer’s Society project testing #psychotherapy for people with dementia.Together, they discuss the importance of therapy in #dementia care, the barriers to access, the development of new therapist competencies, and the lived experience of psychotherapy from both clinical and personal perspectives.TakeawaysPsychotherapy can provide meaningful outcomes for people with dementia.Barriers to accessing therapy include stigma and lack of understanding.Core competencies for therapists are essential for effective care.Family therapy is crucial for supporting families affected by dementia.Training for therapists should include specific skills for working with dementia patients.Research findings highlight the need for better communication about therapy options.The importance of lived experience in shaping research and therapy.Future research should focus on improving access to therapy for families.There is a need for a cultural shift in how dementia is perceived in therapy.Essential links / resources mentioned in the show:Core competences frameworkUK Council for PsychotherapyBritish Association for Counselling and PsychotherapyRecent papers on the topicSponsored by Famileo. Helping families living with dementia stay close with a personalised printed magazine, delivered monthly. Over a quarter of a million families already use Famileo to stay connected. First month free with code DR26. Visit the Famileo Website--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogsMentioned in this episode:Famileo Thank you

In this episode of the Dementia Researcher Podcast, host Dr Anna Volkmer, Associate Professor at UCL and Speech and Language Therapist explores the experiences of young carers in families affected by dementia, the challenges they face, the support they receive, and what more could and should be done.Anna is joined by Dr Patricia Masterson Algar a Lecturer at Bangor University, leading new research funded by Health and Care Research Wales to develop a peer support programme for young carers. Hannah Gardner a Consultant Admiral Nurse for Children and Young People at Dementia UK, advocating nationally for better awareness and support and Gareth and Euan Heslop, father and son who share their lived experience of caring for a wife and mother with young-onset dementia.Together they discuss the often overlooked impact of dementia on children and teenagers, the stigma and isolation young carers face, and how families, schools, and professionals can work together to provide better understanding and support.In this episode:The hidden realities of growing up as a young carer.Stigma, awareness, and the importance of talking openly about dementia.How schools and communities can recognise and support young carers.Why services must consider the whole family, not just the person diagnosed.The role of peer support and what new research hopes to achieve.Voices from lived experience — what young carers really need.Listen to hear how families, researchers, and practitioners are working together to ensure young carers are seen, heard, and supported.For information on the study, or to be involved Find Hannah on LinkedIn or email ([email protected]) / Find Patricia on LinkedIn or email ([email protected])Sponsored by Famileo. Helping families living with dementia stay close with a personalised printed magazine, delivered monthly. Over a quarter of a million families already use Famileo to stay connected. First month free with code DR26. Visit the Famileo Website--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogsMentioned in this episode:Famileo Thank you

In our first episode of the XXplored Women's Brain Health podcast, our resident expert and host Dr Laura Stankeviciute from University of Gothenburg engages with leading neuroscientists Professor Liisa Galea from University of Toronto and Dr Maria Teresa Ferretti from Karolinska Institutet to explore the critical intersection of sex, gender, and brain health.Together our guests discuss their personal journeys into neuroscience, the biological differences in brain health, the impact of hormonal changes, and the vulnerability of women to Alzheimer's disease. The conversation also addresses the barriers to inclusion in clinical research, the implications of neurosexism, and the importance of precision medicine. The episode emphasises the need for early diagnosis and the societal stigma surrounding women's health issues, while advocating for a more inclusive and evidence-based approach to brain health research and treatment.This first show sets the scene for what will be an ongoing series of shows, delivered within the Dementia Researcher podcast.Highlights and takeaways:Released during Menopause Awareness Month — and ahead of World Menopause Day on 18 October — this episode shines a light on how menopause shapes women’s brain health and why it matters for ageing and dementia research.Sex differences shape the brain at every level – structure, hormones, immunity, and function.Menopause is a key vulnerability window for women’s brain ageing and Alzheimer’s risk.Women face higher Alzheimer’s prevalence, not just because they live longer.Women were excluded from trials for decades, leaving dangerous gaps in knowledge.Fear of neurosexism and misunderstandings of feminism slowed progress.Precision medicine must include sex and gender or risk missing early diagnoses.Research funding and clinical guidelines lag far behind need.Momentum is building: younger researchers and public interest are pushing change.Core message: Different ≠ inferior. Diversity drives discovery.Essential links / resources mentioned in the show:Womens Brain Ageing ProjectWomen’s Health Research Cluster (Canada)NIH Policy on Sex as a Biological Variable (SABV)--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

In this episode of the Dementia Researcher Podcast, host Adam Smith (Programme Director at UCL) is joined by Dr Sam Moxon, Dr Lindsey Sinclair, and Dr Ece Bayram to explore the art of delivering lightning talks.Together they share practical advice on structuring short presentations, handling nerves, designing impactful slides, and engaging diverse audiences. With personal anecdotes and strategies from their own conference experiences, this discussion offers valuable guidance for early career researchers preparing to present their work with clarity and confidence.TakeawaysLightning talks are concise presentations, usually under five minutes.Strong preparation is essential for success.An engaging delivery leaves a lasting impression.Slides should support the message, not overwhelm it.Rehearse to the clock to stay on time.Personal touches help connect with the audience.Focus on one key message instead of overloading with detail.Use clear, accessible language throughout.Treat the format as a teaser that sparks curiosity.Lightning talks are excellent opportunities for early career researchers.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

In this episode of the Dementia Researcher podcast, host Adam Smith discusses the upcoming AAIC Neuroscience Next Conference with guests Tricia Nicholson, Dr Amanda Heslgrave, and Kalli Mavromati. They explore the unique hybrid format of the conference, which combines in-person and virtual elements, making it accessible to a global audience.The conversation highlights the focus on biomarkers in dementia research, the importance of early career researchers, and the abstract submission process, providing valuable tips for potential presenters. The episode emphasizes the conference's goal of fostering collaboration and sharing knowledge within the dementia research community.In this episode:The AAIC Neuroscience Next Conference is free and accessible to all. Taking place across 6 countries and online from the 23rd to 26th February 2026.The UK hub will focus on biomarker advancements in dementia diagnosis, with a full in-person conference on the 26th February.The conference aims to support early career researchers in dementia research.A unique hybrid format allows for both in-person and virtual participation.Abstract submissions open on September 22nd and are encouraged from all researchers. From basic science to dementia care.The UK Hub is particularly keen for researchers to submit abstract in biomarker domains.Fluid BiomarkersCognitive AssessmentsPhysiological and Behavioural BiomarkersNeuroimagingTechnology BiomarkersFollow the event on social media #AAICNeuro--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

In this episode we welcome three GBHI Fellows: guest host and filmmaker Michelle Memran, documentary photographer Alex Kornhuber, and social sciences academic Dr Sonata Mačiulskytė. Together they explore the ways in which caregiving, creativity, and change come together in the context of dementia.Drawing on their experiences of supporting loved ones with dementia, they reflect on how these personal journeys have influenced their professional work and shaped their understanding of the disease. The discussion touches on the early signs of dementia, the transformation of relationships through caregiving, and the importance of early diagnosis.The conversation also considers the significance of documenting caregiving experiences and the need to reshape the narrative around dementia. By sharing stories and creative perspectives, the guests highlight how shifting this narrative can foster greater awareness, empathy, and understanding.In this episode:Caregiving is a deeply personal journey that shapes professional work.Recognising early signs of dementia can be challenging but crucial.Relationships with loved ones can transform through the caregiving experience.Early diagnosis can lead to better care and understanding.Documenting caregiving experiences can foster connection and awareness.Language and narrative around dementia need to change for better understanding.Sharing personal stories can help others feel less alone in their caregiving journey.The experience of dementia is unique to each individual and family.Advocacy for brain health should start early in life.Sponsored by Famileo. Helping families living with dementia stay close with a personalised printed magazine, delivered monthly. Over a quarter of a million families already use Famileo to stay connected. First month free with code DR26. Visit the Famileo Website--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

Grant rejection is part of every researcher’s journey — and it never stops, no matter your career stage. In this episode of the Dementia Researcher Podcast, host Dr Fiona McLean (Alzheimer’s Research UK Fellow at the University of Dundee, studying links between metabolic syndrome, learning and memory) speaks with:Dr Sarah Marzi — Senior Lecturer at King’s College London and UK DRI group leader, researching the epigenome in neurodegenerative diseases.Dr Kate Harris — Research Fellow at Newcastle University, soon to be Senior Lecturer, specialising in drug discovery for neurodegenerative diseases.Dr Dayne Beccano-Kelly — UK DRI Future Leader Fellow and group leader at Cardiff University, focusing on synaptic dysfunction in Parkinson’s disease.Together they share personal experiences of failed applications, from crushing first rejections to the resilience that comes with time, blending honest stories with practical strategies.In this episode:First-hand stories of fellowship and project grant rejectionsHow to use reviewer feedback — even when it’s unhelpfulWhy writing style and clarity can change your funding chancesChoosing funders whose remit truly fits your workCoping strategies, from ice cream to badminton to musicBuilding resilience and knowing when to rework or drop an ideaThe value of mentors, networks and peer supportListen to learn why rejection isn’t the end — and how it can be the start of a better grant.Essential links / resources mentioned in the show:Bouncing Back from Rejection - Adam GrantWhat to do when your grant is rejected--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

In this podcast we share a few selected highlights from the Alzheimer’s Association International Conference (AAIC) day two and day three of the main event in Toronto and Online, 27the - 31st July.Dr Shea Andrews, Assistant Professor at University of California San Francisco hosts the show with special guests:Dr Joe Butler, NIHR ARC Research Fellow at University of SunderlandDr Lindsey Sinclair, Clinical Research Fellow & Consultant in Old Age Psychiatrist at University of BristolDr Harriet Demnitz-King, Post-doctoral Research Fellow at Queen Mary University of LondonThe AAIC brings together distinguished basic scientists, clinical researchers, early career investigators, clinicians and the care research community at the largest and most influential international conference on dementia science. They share theories and breakthroughs while exploring opportunities to accelerate work and elevate careers.Main plenary talks from the day came from Professor Sharon Naismith from University of Sydney, Australia giving a talk titled "Waking Up to the Importance of Sleep in MCI and AD" and Professor Katrin Andreasson, M.D. with a talk titled "Restoring Hippocampal Glucose Metabolism Rescues Cognition Across Alzheimer’s Disease Pathologies".--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

In this podcast we share a few selected highlights from the Alzheimer’s Association International Conference (AAIC) day two and day three of the main event in Toronto and Online, 27the - 31st July.Dr Connor Richardson, NIHR / Alzheimer's Society Dem Comm Research Fellow from University of Newcastle hosts the show with special guests:Sára Zsadányi, PhD Student at Sant Pau Memory Unit – Neuroimaging Core and Universitat Autonoma de BarcelonaDr Tatiana Giovannucci, Alzheimer's Association Research FellowDr Richard Oakley, Associate Director of Research at Alzheimer's SocietyThe AAIC brings together distinguished basic scientists, clinical researchers, early career investigators, clinicians and the care research community at the largest and most influential international conference on dementia science. They share theories and breakthroughs while exploring opportunities to accelerate work and elevate careers.Main plenary talks from the day came from Professor Inhee Mook-Jung Seoul National University, Korea with a talk titled "The Gut-Brain Axis in Alzheimer’s Disease: Unraveling Pathogenesis and Exploring Novel Therapeutic Strategies" and Dr Juan Fortea, Memory Unit Director — Hospital de la Santa Creu i Sant Pau, Spain with a talk titled "Alzheimer’s Disease in Down Syndrome".--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

In this podcast we share a few selected highlights from the Alzheimer’s Association International Conference (AAIC) first and second day of the main event in Toronto and Online, 27the - 31st July.Dr James Brady, Postdoctoral Research Fellow at University of Tasmania hosts the show with special guests:Dr Lucy Stirland, Academic Old Age Psychiatrist at The University of EdinburghDr Isabel Castanho, Instructor at the Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical SchoolFelix Wittmann, Research Fellow & PhD candidate at Leipzig UniversityThe AAIC brings together distinguished basic scientists, clinical researchers, early career investigators, clinicians and the care research community at the largest and most influential international conference on dementia science. They share theories and breakthroughs while exploring opportunities to accelerate work and elevate careers.Main plenary talks from the day came from Professor Katerina Akassoglou, University of California, San Francisco, United States exploring Neurovascular Interactions in Alzheimer’s Disease: From Mechanisms to Treatments + Professor Maria Grazia Spillantini, from University of Cambridge United Kingdom for her plenary titled 'The Multiple Facets of Tau Pathology'.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

In this podcast we share a few selected highlights from the Alzheimer’s Association International Conference (AAIC) pre-conference and first day of the main event in Toronto and Online, 27the - 31st July.Dr Tamlyn Watermeyer hosts the show with special guests:Dr Emily Ho, Assistant Professor at Northwestern UniversityDr Laura Stankeviciute, Postdoctoral Researcher & Scientific Project Manager at University of GothenburgJoseph Russell, NIHR Research Assistant at Northumbria UniversityThe AAIC brings together distinguished basic scientists, clinical researchers, early career investigators, clinicians and the care research community at the largest and most influential international conference on dementia science. They share theories and breakthroughs while exploring opportunities to accelerate work and elevate careers.Main plenary talk from the day came from Sylvia Villeneuve, Ph.D. Associate Professor, Department of Psychiatry — McGill University, Canada talk about Biomarker and Clinical Trajectories of Preclinical AD.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

Welcome to the sixth season of the Dementia Researcher X ISTAART PIA Relay Podcast. This series features interviews with ISTAART PIA committee members talking about their research, the research landscape of their fields, and the work of the ISTAART Professional Interest Areas (PIA) they represent. As we build up to the Alzheimer’s Association International Conference in Toronto, join us for daily episodes that showcase the remarkable work being done in various research fields.In this episode, Dr Shana Stites interviews Dr Alexa Pichet-Binette, Assistant Professor at University of Montreal and Education Chair of the Neuroimaging PIA. Alexa discusses her work using PET and MRI imaging, and how fluid biomarkers like plasma-based assays are reshaping Alzheimer's diagnostics. She also highlights the role of the Neuroimaging PIA in ISTAART, including collaborations, working groups, and the popular “year in review” sessions. They explore how these initiatives support early career researchers and foster community, with a preview of pre-conference workshops at AAIC 2025 in Toronto.The Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) convenes the global Alzheimer’s and dementia science community. Members share knowledge, fuel collaboration and advance research to find more effective ways to detect, treat and prevent Alzheimer’s and other dementias. Professional Interest Areas (PIA) are an assembly of ISTAART members with common subspecialties or interests.There are currently 30 PIAs covering a wide range of interests and fields, from the PIA to Elevate Early Career Researchers to Biofluid Based Biomarkers and everything in between.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

Welcome to the sixth season of the Dementia Researcher X ISTAART PIA Relay Podcast. This series features interviews with ISTAART PIA committee members talking about their research, the research landscape of their fields, and the work of the ISTAART Professional Interest Areas (PIA) they represent. As we build up to the Alzheimer’s Association International Conference in Toronto, join us for daily episodes that showcase the remarkable work being done in various research fields.In this episode, Professor Owen Carmichael talks with Dr Shana Stites, Assistant Professor at University of Pennsylvania and Chair of the ISTAART Diversity and Disparities PIA. In this discussion they explore the importance of inclusive participation in dementia research, the challenges of equitable access to research and care, and the shift toward more community-engaged approaches. The conversation highlights barriers like limited access to healthcare, the ethics of stipends, and the value of transparency, reciprocity, and representation in Alzheimer's disease and related research. They also talk about the wider work and aims of the PIA and what they have planned for the upcoming AAIC.The Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) convenes the global Alzheimer’s and dementia science community. Members share knowledge, fuel collaboration and advance research to find more effective ways to detect, treat and prevent Alzheimer’s and other dementias. Professional Interest Areas (PIA) are an assembly of ISTAART members with common subspecialties or interests.There are currently 30 PIAs covering a wide range of interests and fields, from the PIA to Elevate Early Career Researchers to Biofluid Based Biomarkers and everything in between.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

Welcome to the sixth season of the Dementia Researcher X ISTAART PIA Relay Podcast. This series features interviews with ISTAART PIA committee members talking about their research, the research landscape of their fields, and the work of the ISTAART Professional Interest Areas (PIA) they represent. As we build up to the Alzheimer’s Association International Conference in Toronto, join us for daily episodes that showcase the remarkable work being done in various research fields.In this episode, Professor Natalie Phillips interviews Professor Owen Carmichael, Director of Biomedical Imaging at Pennington Biomedical Research Center and incoming chair of the ISTAART Nutrition, Metabolism, and Dementia PIA. Owen shares his journey from computer science to neuroscience, and how his imaging work investigates how diet and metabolism shape dementia risk. They explore the promise of precision nutrition, the challenges of studying lifelong dietary exposure, and the vital role of olfaction and sensory health in nutrition. The episode also discusses the importance of inclusive research and lifelong data to understand and prevent cognitive decline. The show rounds-up the PIAs upcoming work at the AAIC, and the work of the PIA.The Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) convenes the global Alzheimer’s and dementia science community. Members share knowledge, fuel collaboration and advance research to find more effective ways to detect, treat and prevent Alzheimer’s and other dementias. Professional Interest Areas (PIA) are an assembly of ISTAART members with common subspecialties or interests.There are currently 30 PIAs covering a wide range of interests and fields, from the PIA to Elevate Early Career Researchers to Biofluid Based Biomarkers and everything in between.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

Welcome to the sixth season of the Dementia Researcher X ISTAART PIA Relay Podcast. This series features interviews with ISTAART PIA committee members talking about their research, the research landscape of their fields, and the work of the ISTAART Professional Interest Areas (PIA) they represent. As we build up to the Alzheimer’s Association International Conference in Toronto, join us for daily episodes that showcase the remarkable work being done in various research fields.In this episode, Dr Marta del Campo interviews Natalie Phillips, Chair of the Sensory Health and Cognition PIA and Professor of Psychology at Concordia University. Together, they discuss the role of hearing, vision, and olfaction in cognitive ageing and dementia risk. They explore mechanisms behind these links, from cognitive load to social isolation, and discuss emerging biomarker research, challenges in clinical implementation, and how this new ISTAART PIA is fostering interdisciplinary collaboration. The episode also previews upcoming activities at AAIC and highlights opportunities for early career researchers to get involved.The Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) convenes the global Alzheimer’s and dementia science community. Members share knowledge, fuel collaboration and advance research to find more effective ways to detect, treat and prevent Alzheimer’s and other dementias. Professional Interest Areas (PIA) are an assembly of ISTAART members with common subspecialties or interests.There are currently 30 PIAs covering a wide range of interests and fields, from the PIA to Elevate Early Career Researchers to Biofluid Based Biomarkers and everything in between.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

Welcome to the sixth season of the Dementia Researcher X ISTAART PIA Relay Podcast. This series features interviews with ISTAART PIA committee members talking about their research, the research landscape of their fields, and the work of the ISTAART Professional Interest Areas (PIA) they represent. As we build up to the Alzheimer’s Association International Conference in Toronto, join us for daily episodes that showcase the remarkable work being done in various research fields.In this Relay Podcast episode, Dr Colin Groot interviews Dr Marta Del Campo, Head Fluid Biomarker Facility; Ramón y Cajal Research fellow at BarcelonaBeta Brain Research Center and chair of the ISTAART Biofluid Based Biomarkers PIA. Together, they talk about recent advances in fluid biomarkers in dementia research, and explore the growing role of plasma biomarkers, integration with clinical trials, challenges with reproducibility and diversity, and the promise of proteomics and AI. Marta also reflects on the work of ISTAART, their plans for AAIC, the value of publishing negative findings, and why ISTAART offers vital opportunities for early career researchers.The Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) convenes the global Alzheimer’s and dementia science community. Members share knowledge, fuel collaboration and advance research to find more effective ways to detect, treat and prevent Alzheimer’s and other dementias. Professional Interest Areas (PIA) are an assembly of ISTAART members with common subspecialties or interests.There are currently 30 PIAs covering a wide range of interests and fields, from the PIA to Elevate Early Career Researchers to Biofluid Based Biomarkers and everything in between.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

Welcome to the sixth season of the Dementia Researcher X ISTAART PIA Relay Podcast. This series features interviews with ISTAART PIA committee members talking about their research, the research landscape of their fields, and the work of the ISTAART Professional Interest Areas (PIA) they represent. As we build up to the Alzheimer’s Association International Conference in Toronto, join us for daily episodes that showcase the remarkable work being done in various research fields.In this episode, Dr Alexa Pichet-Binette interviews Dr Colin Groot, an expert in neuroimaging and atypical Alzheimer's disease from Amsterdam University Medical Centre. They discuss the clinical and biological diversity within atypical variants such as posterior cortical atrophy (PCA), language and behavioural forms, and CBSAD. Colin shares insights into ongoing studies on tau PET, mortality, subtyping PCA, and how ISTAART’s Atypical PIA is pushing forward international collaboration and inclusivity in clinical trials and diagnostic criteria.The Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) convenes the global Alzheimer’s and dementia science community. Members share knowledge, fuel collaboration and advance research to find more effective ways to detect, treat and prevent Alzheimer’s and other dementias. Professional Interest Areas (PIA) are an assembly of ISTAART members with common subspecialties or interests.There are currently 30 PIAs covering a wide range of interests and fields, from the PIA to Elevate Early Career Researchers to Biofluid Based Biomarkers and everything in between.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

In this episode of the Dementia Researcher Podcast, Dr Kamar Ameen-Ali is joined by Dr Ahmad Khundakar from Teesside University, Anna Wilson from South Tees Hospitals NHS Foundation Trust, and Professor Mani Santhana Krishnan from Tees, Esk and Wear Valleys NHS Foundation Trust to explore the complex and often misunderstood relationship between delirium and dementia.The discussion unpacks why these two conditions are so frequently confused, how this confusion can lead to misdiagnosis and harm, and why recognising the difference matters deeply, particularly in hospital and care environments. Professor Krishnan shares clinical insights on how delirium manifests and why it is often underdiagnosed, especially in older adults and people with pre-existing cognitive conditions. Anna Wilson highlights how screening tools like the 4AT are helping clinicians respond more effectively, while also emphasising the importance of person-centred care. Dr Khundakar brings both scientific expertise and a deeply personal perspective, sharing how his own family experience of delirium shaped his research and understanding of care needs.Together, they discuss different forms of delirium, such as hypoactive and hyperactive types, and explore the importance of recognising sudden changes in behaviour. The episode also addresses wider system issues — from gaps in professional training to the need for improved support for families and carers. With an emphasis on prevention, non-drug interventions, and modifiable risk factors, this is an essential conversation for anyone working in dementia research, healthcare, or policy, as well as for families who want to better understand and advocate for their loved ones.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

The Minds in Motion Podcast from Dementia Researcher in association with the NIHR Applied Research Collaborations and Alzheimer’s Society, brings together NIHR Dem Comm Research Fellows, to talk about their research and careers.In this final episode of the current series, Trevor Salomon is joined by Dr Pippa Collins from the University of Southampton to interview Dr Sarah Kate Smith.Sarah is based at The University of Manchester and NIHR ARC Greater Manchester, and is an NIHR and Alzheimer’s Society Demm Comm Fellow. Her work focuses on brain health and dementia prevention, particularly examining how physical activity in midlife could reduce the risk of developing dementia later in life. With a background in psychology and a PhD in health services research, Sarah brings expertise in creative and inclusive research methodologies that enable the involvement of people living with dementia and their families.In this conversation, we explore the challenges of dementia prevention research, how risk reduction differs from the idea of outright prevention, and the importance of public and patient involvement in designing ethical and accessible interventions. Sarah also shares insight into an upcoming project exploring access to brain health clinics among minority ethnic groups and reflects on her career journey, motivations, and what keeps her going.Dem Comm is a 2 year programme funded by the National Institute of Health and Care Research and the Alzheimer's Society. It supports a new generation of dementia research leaders, bringing together researchers from different multidisciplinary backgrounds to encourage cross-cutting and community-orientated dementia research projects that can address key gaps in the evidence around dementia care and support, delivering transformative translational research.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

In this episode of the Dementia Researcher podcast, host Dr Amanda Heslegrave leads an insightful discussion on one of the most promising developments in dementia diagnostics: blood-based biomarkers.Once a purely research-focused tool, these tests are now moving closer to clinical practice, offering the possibility of earlier, easier, and less invasive diagnosis of neurodegenerative diseases. But while the science advances rapidly, questions remain about how ready the healthcare system is to adopt them.Amanda is joined by two expert guests:Dr Jay Amin, University of Southampton – A clinician specialising in dementia, researching inflammation and immune biomarkers, particularly focused on diagnostics and prognosis.Dr Mark Roskey, Quanterix – Senior VP involved in developing ultra-sensitive biomarker detection technologies crucial for dementia research.Together, they explore the current state of play—from recent breakthroughs in markers like p-Tau217 to practical hurdles such as infrastructure, standardisation, and clinician education. They also reflect on ethical considerations surrounding early diagnosis and the importance of cross-sector collaboration to ensure these tools benefit as many people as possible.Topics Covered:The current landscape and promise of blood-based biomarkersRecent scientific and technological breakthroughsBarriers to clinical implementation and public adoptionEthical questions around early diagnosis--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

The Minds in Motion Podcast from Dementia Researcher in association with the NIHR Applied Research Collaborations and Alzheimer’s Society, brings together NIHR Dem Comm Research Fellows, to talk about their research and careers.In this second series, we hear from five of the Dem Comm Fellows each taking a turn as co-host and guest. Alongside the researchers we have the incredible Trevor Salomon, Alzheimer’s Society Volunteer & Chair of the European Dementia Carers Working Group as our permanent co-host and anchor.In show Trevor is joined by Dr Katie Breheny from Bristol University and NIHR Applied Research Collaboration (ARC) West to interview Dr Pippa Collins.Pippa Collins is an Advanced Clinical Practitioner and NIHR / Alzheimer’s Society Dem Comm Fellow based at the University of Southampton and NIHR ARC Wessex. Her research primarily addresses the critical aspects of end-of-life care, frailty, and dementia. In this discussion, we explore her work aimed at enhancing the recognition and management of the end-of-life period for people living with dementia. Pippa highlights the importance of shifting from traditional medicalised models of palliative care towards a holistic and personalised "palliative approach," focusing on recognising individual trajectories and vulnerabilities. Her goal is to foster improvements in dementia care practices by better educating healthcare professionals, supporting families, and integrating patient-centred care pathways that respect each individual's emotional, social, and cognitive needs.Dem Comm is a 2 year programme funded by the National Institute of Health and Care Research and the Alzheimer's Society. It supports a new generation of dementia research leaders, bringing together researchers from different multidisciplinary backgrounds to encourage cross-cutting and community-orientated dementia research projects that can address key gaps in the evidence around dementia care and support, delivering transformative translational research.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

Recorded live at the BNA 2025 Festival of Neuroscience, this special episode of the Dementia Researcher Podcast explores how researchers can build visibility in authentic and meaningful ways.Host Dr Emma Yhnell from Cardiff University is joined by Dr Ian Harrison from University College London, Dr Ekta Patel from the Medicines Discovery Catapult and Professor Fiona Ducotterd from the ARUK Drug Discovery Institute at UCL. They provide practical and personal discussion on raising your academic profile — both online and in real life.Together, they reflect on the challenges and benefits of self-promotion, share strategies to overcome imposter syndrome, and offer advice on making the most of networking opportunities. They also talk about the power of storytelling, volunteering, and showing up as your real self in academic spaces.Whether you're just getting started or trying to take the next step in your career, this episode offers relatable insights and actionable tips.Top Takeaways:Start small — writing blog posts, joining a committee, or talking to someone new at a conference all count.Reframe self-promotion as sharing your work with purpose and generosity.Visibility builds confidence, not the other way around — and it’s something you can practise over time.Your perspective matters — you don’t need to be the loudest voice, just an authentic one.The people behind the science are just as important as the science itself.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

In this podcast, host Dr Anna Volkmer explores the use of Lego Serious Play as a research tool / methodology in dementia and neurodegenerative disease studies.Traditionally used in therapy and organisational development, Lego Serious Play is now finding its way into the research world—helping researchers, participants, and stakeholders express complex ideas, foster collaboration, and build deeper insights (literally and metaphorically).Anna is joined by a panel of expert guests Dr Warren Donnellan, University of Liverpool – a trained facilitator of Lego Serious Play who applies it to resilience and carer research. Dr Alys Griffiths, University of Sheffield – who has integrated the method into dementia studies and her work in Motor Neuron Disease. Dr Joe Langley, Sheffield Hallam University – known for combining design thinking and participatory research methods, including Lego Serious Play, in health and care settings.Together, they explore the origins, applications, and benefits of this playful method, share case studies, and reflect on how building with Lego can break down communication barriers and empower participants—particularly those with dementia.Topics covered:What is Lego Serious Play and how does it work in research?Insights into resilience and the carer experienceUsing play to unlock communication in dementia researchHow design thinking intersects with health research--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

This year's AD/PD Conference was held in Vienna, Austria from the 1st to 5th April. In this first of a two-part special we bring you highlights from the first three days of the conference.The AD/PD Conference focuses on basic science and translational and clinical research bringing New insights on disease mechanisms and etiologies, the latest findings from clinical trials, innovative outlooks on therapy and prevention and advances in diagnostic markers.In this special on-location recording our guest host Dr Amanda Heslegrave from UK Dementia Research Institute at University College London talks with Dr Loukia Katsouri from the UCL Gatsby Foundation, Dr Anna Mallach from the UK Dementia Research Institute at Imperial College London and Dr Imogen Swift, Research Scientist at Vesper Bio.Here are just a few highlights from the discussion:Can AI spot cognitive decline in mice before humans can? Discover how machine learning is transforming mouse model analysis to predict impairment – and the surprising gender and breeding effects researchers uncovered.Drug repurposing breakthroughs: affordable hope on the horizon? Find out why microglial activity, mitochondrial senescence, and asthma meds could be the future of dementia drug discovery – without starting from scratch.Parkinson’s redefined – biologically, not clinically. A bold proposal to ditch clinical diagnosis in Parkinson’s research in favour of biomarker-based subtyping. Could it revolutionise how trials are run?Astrocytes take centre stage – and they might be phagocytosing synapses. New data shows waves of astroglial activity and potential astro-microglial crosstalk in Parkinson’s disease – with serious implications for how we model disease.Could a finger prick diagnose dementia? From dried blood spot kits to large-scale remote testing, hear how researchers are racing to make brain biomarker screening as simple as a home test.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

This year's AD/PD Conference was held in Vienna, Austria from the 1st to 5th April. In this second of a two-part special we bring you highlights from the last three days of the conference.The AD/PD Conference focuses on basic science and translational and clinical research bringing New insights on disease mechanisms and etiologies, the latest findings from clinical trials, innovative outlooks on therapy and prevention and advances in diagnostic markers.In this special on-location recording our guest host Dr Isabel Castanho from Harvard Medical School talks with Dr Emma Garland from The University of Sheffield, Susan Rohde from UMC Amsterdam and Dr Martyna Matuszyk from the Alzheimer's Society.Here are just a few highlights from the discussion:"This is why we do the science." A powerful and emotional talk from Trevor Salamon, sharing his wife's journey with young onset dementia, reminded the audience what it's all really about.Can your gut give you Parkinson’s? Discover new research showing how toxic proteins may travel from the gut to the brain — and how mini organoids are helping researchers prove it.Microglia, mice, and human brains… all pointing to the same gene? Explore how two researchers independently found SPP1 upregulated in Alzheimer’s immunotherapy studies — in both mice and humans.PhD students are stealing the show. From organoid development to cutting-edge methylation studies, early-career researchers are producing some of the most exciting work on display."I saw your name on the poster and had to say hello". Hear how chance meetings, shared lab lines, and QR code posters are turning scientific conferences into hubs of unexpected connection.--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs

In this episode of the Dementia Researcher Podcast, guest host Dr Sam Moxon is joined by Dr Adam Schuller, Dr Savannah Rocha-Wrigley, and Megan Hager from Colorado State University's Tjalkens Lab to explore the significant yet often overlooked impact of environmental toxins on dementia and neurodegenerative diseases.This fascinating discussion sheds light on how substances such as pesticides, heavy metals, wildfire smoke, and air pollution can trigger changes in glial cells, such as astrocytes and microglia, which may lead to dementia. The experts share insights into groundbreaking experimental models, imaging technologies, and the importance of early intervention and prevention strategies to reduce toxin-related risks.Key Topics:Defining environmental toxins and their relevance to dementiaRole of astrocytes and microglia in neurodegenerationTranslational neurotoxicology modelsAdvanced AI imaging and analysis techniquesPreventative strategies to mitigate environmental risks--A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.Leave us a tip:https://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcherWe gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.Subscribe to our sister show 'Dementia Researcher The Blogs':https://podfollow.com/dementia-researcher-blogs